Robert M. Brenner, M.D.

Executive Vice President of Research & Development

Robert M. Brenner, M.D. joined Codiak from Orionis Biosciences where he was Executive Vice President and Chief Medical Officer. Prior to that, Dr. Brenner was President and Chief Executive Officer of AlloCure, a clinical-stage regenerative medicine company. Prior to AlluCure, Dr. Brenner was at AMAG Pharmaceuticals where he was Senior Vice President of Medical Affairs, Dr. Brenner began his career at Amgen where he served in nephrology leadership roles both in clinical development and medical affairs. During his career, Dr. Brenner has contributed to the registrational strategy and approval of new medicines and served as a key liaison to the medical community, professional societies, and regulatory agencies.

Dr. Brenner received his B.A. from Johns Hopkins University and his M.D. from Albert Einstein College of Medicine. He completed a residency in internal medicine at Brigham and Women's Hospital and a fellowship in nephrology at Stanford University Medical Center.